Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandhya Pruthi

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Canadian Family Physician Medecin De Famille Canadien|October 15, 2016
Primary care providers' experiences with and perceptions of personalized genomic medicineJune C Carroll, Tutsirai Makuwaza, Donna P Manca, et al.
European Urology|April 23, 2015
Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trialBoyd R Viers, Deborah J Lightner, Marcelino E Rivera, et al.
Mayo Clinic Proceedings|December 10, 2025
Ethically Integrating Genomics in Primary Care: An Invitation to Share Implementation Best Practices, Elisa J F Houwink, Karen M Meagher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast CancerSmita Bhatia, Melanie R Palomares, Lindsey Hageman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factorsBrent Mabey, Elisha Hughes, Matthew Kucera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline UpdateKala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Canadian Family Physician Medecin De Famille Canadien|October 15, 2016
Primary care providers' experiences with and perceptions of personalized genomic medicineJune C Carroll, Tutsirai Makuwaza, Donna P Manca, et al.
European Urology|April 23, 2015
Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trialBoyd R Viers, Deborah J Lightner, Marcelino E Rivera, et al.
Mayo Clinic Proceedings|December 10, 2025
Ethically Integrating Genomics in Primary Care: An Invitation to Share Implementation Best Practices, Elisa J F Houwink, Karen M Meagher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast CancerSmita Bhatia, Melanie R Palomares, Lindsey Hageman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2024
Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factorsBrent Mabey, Elisha Hughes, Matthew Kucera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2014
Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancerElizabeth Maunsell, Paul E Goss, Rowan T Chlebowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2020
Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast CancerSiddhartha Yadav, Chunling Hu, Steven N Hart, et al.
Journal of the National Cancer Institute|October 16, 2024
Polygenic risk scores stratify breast cancer risk among women with benign breast diseaseMark E Sherman, Stacey J Winham, Robert A Vierkant, et al.
Pageof 13